April 9, 2020
Japanese generic major Nichi-Iko Pharmaceutical has launched voluntary recalls for a whopping 12 APIs/15 products due to quality issues and deviations from approved procedures, stoking concerns that it could spill over into other manufacturers and disrupt future supplies to healthcare...read more